African drugmakers develop local treatments for sickle cell disease

Senegal’s locally manufactured hydroxyurea, alongside Nigeria’s sickle-cell research, is strengthening Africa’s response to a disease that disproportionately affects the continent—but access, affordability and wider care remain major challenges.

This story was originally reported by IOL News. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.